Regeneron Pharmaceuticals Inc Stock Ownership - Who owns Regeneron Pharmaceuticals?

Insider buying vs selling

Have Regeneron Pharmaceuticals Inc insiders been buying or selling?
Andrew J. MurphyEVP Research2023-11-14347$802.63
Andrew J. MurphyEVP Research2023-11-141,601$799.48
Andrew J. MurphyEVP Research2023-11-141,614$798.63
Andrew J. MurphyEVP Research2023-11-14877$801.56
Andrew J. MurphyEVP Research2023-11-1419$805.00
Andrew J. MurphyEVP Research2023-11-1419$804.89
Andrew J. MurphyEVP Research2023-11-14330$803.38
Andrew J. MurphyEVP Research2023-11-14382$800.55
Andrew J. MurphyEVP Research2023-11-14752$794.57
Andrew J. MurphyEVP Research2023-11-14347$795.38

1 of 27

REGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when REGN insiders and whales buy or sell their stock.

REGN Shareholders

What type of owners hold Regeneron Pharmaceuticals Inc stock?
Fmr LLC9.03%9,840,892$7.88BInstitution
Blackrock Inc8.15%8,875,309$7.11BInstitution
Vanguard Group Inc8.08%8,798,505$7.05BInstitution
Jpmorgan Chase Co6.78%7,389,154$5.92BInstitution
Capital World Investors4.69%5,107,339$4.09BInstitution
State Street Corp4.43%4,829,106$3.87BInstitution
Capital International Investors2.73%2,974,338$2.38BInstitution
Dodge Cox2.18%2,372,998$1.90BInstitution
Geode Capital Management LLC2.13%2,319,986$1.86BInstitution

1 of 3

REGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
REGN69.06%30.94%Net SellingNet Selling
VRTX89.97%1.48%Net SellingNet Selling
SGEN45.16%54.84%Net SellingNet Selling
MRNA63.71%21.74%Net SellingNet Selling

Regeneron Pharmaceuticals Stock Ownership FAQ

Who owns Regeneron Pharmaceuticals?

Regeneron Pharmaceuticals (NASDAQ: REGN) is owned by 82.43% institutional shareholders, 36.93% Regeneron Pharmaceuticals insiders, and 0.00% retail investors. Sanofi is the largest individual Regeneron Pharmaceuticals shareholder, owning 36.52M shares representing 33.52% of the company. Sanofi's Regeneron Pharmaceuticals shares are currently valued at $29.26B.

If you're new to stock investing, here's how to buy Regeneron Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.